These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

592 related articles for article (PubMed ID: 24556839)

  • 1. Post-translational modifications of intermediate filament proteins: mechanisms and functions.
    Snider NT; Omary MB
    Nat Rev Mol Cell Biol; 2014 Mar; 15(3):163-77. PubMed ID: 24556839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assays for Posttranslational Modifications of Intermediate Filament Proteins.
    Snider NT; Omary MB
    Methods Enzymol; 2016; 568():113-38. PubMed ID: 26795469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic organisation of intermediate filaments and associated proteins during the cell cycle.
    Foisner R
    Bioessays; 1997 Apr; 19(4):297-305. PubMed ID: 9136627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presence of fibroblast-type intermediate filaments (vimentin) and absence of neurofilaments in pigmented nevi and malignant melanomas.
    Miettinen M; Lehto VP; Virtanen I
    J Cutan Pathol; 1983 Jun; 10(3):188-92. PubMed ID: 6190849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation of Intermediate Filament Proteins from Multiple Mouse Tissues to Study Aging-associated Post-translational Modifications.
    Battaglia RA; Kabiraj P; Willcockson HH; Lian M; Snider NT
    J Vis Exp; 2017 May; (123):. PubMed ID: 28570536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence that formation of an intermediate filament-protein complex plays a primary role in aggregation of neurofilaments, glial fibrillary acidic protein (GFAP)-filaments and vimentin-filaments by 2,5-hexanedione.
    Durham HD; Salera I; Dahrouge S
    J Neuropathol Exp Neurol; 1989 Mar; 48(2):197-211. PubMed ID: 2466109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytoskeleton-associated proteins: their role as cellular integrators in the neoplastic process.
    Bernal SD; Stahel RA
    Crit Rev Oncol Hematol; 1985; 3(3):191-204. PubMed ID: 2412718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent insight into intermediate filament structure.
    Eldirany SA; Lomakin IB; Ho M; Bunick CG
    Curr Opin Cell Biol; 2021 Feb; 68():132-143. PubMed ID: 33190098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coexpression of intermediate filaments in squamous cell carcinomas of upper aerodigestive tract before and after radiation and chemotherapy.
    Fischer HP; Wallner F; Maier H; Weber K; Osborn M; Altmannsberger M
    Lab Invest; 1989 Oct; 61(4):433-9. PubMed ID: 2477642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intermediate filament proteins are reliable immunohistological biomarkers to help diagnose multiple tissue-specific diseases.
    Doganyigit Z; Eroglu E; Okan A
    Anat Histol Embryol; 2023 Sep; 52(5):655-672. PubMed ID: 37329162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolution of homologous domains of cytoplasmic intermediate filament proteins and lamins.
    Blumenberg M
    Mol Biol Evol; 1989 Jan; 6(1):53-65. PubMed ID: 2921943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "Heads and tails" of intermediate filament phosphorylation: multiple sites and functional insights.
    Omary MB; Ku NO; Tao GZ; Toivola DM; Liao J
    Trends Biochem Sci; 2006 Jul; 31(7):383-94. PubMed ID: 16782342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Posttranslational modifications of the cytoskeleton.
    MacTaggart B; Kashina A
    Cytoskeleton (Hoboken); 2021 Apr; 78(4):142-173. PubMed ID: 34152688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-translational modifications soften vimentin intermediate filaments.
    Kraxner J; Lorenz C; Menzel J; Parfentev I; Silbern I; Denz M; Urlaub H; Schwappach B; Köster S
    Nanoscale; 2021 Jan; 13(1):380-387. PubMed ID: 33351020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of assembly-disassembly of intermediate filaments in vitro.
    Inagaki M; Gonda Y; Ando S; Kitamura S; Nishi Y; Sato C
    Cell Struct Funct; 1989 Jun; 14(3):279-86. PubMed ID: 2476247
    [No Abstract]   [Full Text] [Related]  

  • 16. Providing cellular signposts--post-translational modifications of intermediate filaments.
    Hyder CL; Pallari HM; Kochin V; Eriksson JE
    FEBS Lett; 2008 Jun; 582(14):2140-8. PubMed ID: 18502206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-Translational Modification of Lamins: Mechanisms and Functions.
    Zheng M; Jin G; Zhou Z
    Front Cell Dev Biol; 2022; 10():864191. PubMed ID: 35656549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The human spiral ganglion.
    Anniko M; Arnold W; Stigbrand T; Ström A
    ORL J Otorhinolaryngol Relat Spec; 1995; 57(2):68-77. PubMed ID: 7537360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignant melanomas contain only the vimentin type of intermediate filaments.
    Caselitz J; Jänner M; Breitbart E; Weber K; Osborn M
    Virchows Arch A Pathol Anat Histopathol; 1983; 400(1):43-51. PubMed ID: 6190301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intermediate filament proteins during carcinogenesis and apoptosis (Review).
    Prasad S; Soldatenkov VA; Srinivasarao G; Dritschilo A
    Int J Oncol; 1999 Mar; 14(3):563-70. PubMed ID: 10024692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.